Physician
Fefer-Sadler, Sandra
Fefer-Sadler, Sandra was paid $4.98M by Medicaid between Jan 2018 and Dec 2024, across 75 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoFEFER-SADLER, SANDRA
HAVERSTRAW, NY 10927
HAVERSTRAW, NY 10927
33aNPI1245211309assigned 11/07/2005
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$4.98M
24GClaims118,594
24DCodes billed75
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in New York
Rank by total paid#9 of 161
Median peer was paid$100K
This provider vs. median50×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,828 | $1.03M | |
| 2019 | 19,733 | $817K | |
| 2020 | 12,537 | $549K | |
| 2021 | 17,909 | $652K | |
| 2022 | 17,282 | $717K | |
| 2023 | 15,381 | $642K | |
| 2024incomplete | 13,924 | $580K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 30,938 | 23,083 | $2.06M |
| 99051 | 10% | 4,788 | 4,325 | $520K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 6,092 | 5,527 | $519K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.7% | 8,816 | 8,252 | $237K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.2% | 6,187 | 5,345 | $210K |
| 4124F | 3.1% | 7,818 | 6,455 | $153K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.8% | 2,139 | 2,090 | $142K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.7% | 3,200 | 2,990 | $136K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.7% | 1,885 | 1,848 | $133K |
| 96111 | 2.5% | 1,138 | 1,122 | $127K | |
| 92586 | 2.1% | 1,385 | 1,382 | $104K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.0% | 1,635 | 1,568 | $98K |
63 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.5% | 1,089 | $73K |
| 95930 | 1.5% | 1,101 | $73K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 15,623 | $62K |
| 92588 | 1.2% | 1,276 | $58K | |
| 92567 | <1% | 2,205 | $29K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,452 | $29K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,768 | $29K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,181 | $28K |
| 0001A | <1% | 457 | $15K | |
| 0002A | <1% | 398 | $15K | |
| 99403 | <1% | 185 | $13K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 120 | $12K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 104 | $10K |
| 90461 | <1% | 749 | $9K | |
| 94667 | <1% | 360 | $8K | |
| 99401 | <1% | 251 | $8K | |
| 0071A | <1% | 191 | $8K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 388 | $7K |
| 90677 | <1% | 218 | $7K | |
| 0072A | <1% | 159 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 330 | $5K |
| 0003A | <1% | 131 | $5K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 706 | $5K |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | <1% | 99 | $4K |
| 99173 | <1% | 308 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 271 | $4K |
| 83655 | <1% | 237 | $3K | |
| 90756 | <1% | 126 | $2K | |
| 81000 | <1% | 572 | $2K | |
| 0073A | <1% | 48 | $2K | |
| 85018 | <1% | 786 | $2K | |
| 36410 | <1% | 109 | $1K | |
| 0011A | <1% | 48 | $1K | |
| 0012A | <1% | 37 | $979.38 | |
| 99381 | <1% | 16 | $917.52 | |
| 99402 | <1% | 17 | $876.69 | |
| 90670 | <1% | 655 | $875.27 | |
| 90686 | <1% | 2,098 | $764.65 | |
| 90480 | <1% | 25 | $662.73 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 12 | $503.90 |
| 96127 | <1% | 140 | $385.79 | |
| 92587 | <1% | 14 | $245.70 | |
| 90651 | <1% | 426 | $177.64 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 15 | $159.20 |
| 86580 | <1% | 13 | $115.62 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 56 | $99.00 |
| 90680 | <1% | 439 | $88.28 | |
| 90672 | <1% | 177 | $80.64 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 234 | $78.35 |
| 90715 | <1% | 127 | $77.04 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 510 | $76.60 |
| 90744 | <1% | 233 | $29.90 | |
| 36416 | <1% | 898 | $13.50 | |
| 90734 | <1% | 211 | $1.00 | |
| 90621 | <1% | 58 | $1.00 | |
| 91300 | <1% | 499 | $0.01 | |
| 90698 | 0% | 863 | $0.00 | |
| 99000 | 0% | 41 | $0.00 | |
| 91301 | 0% | 87 | $0.00 | |
| 90710 | 0% | 238 | $0.00 | |
| 90633 | 0% | 176 | $0.00 | |
| 99080 | 0% | 171 | $0.00 | |
| 90685 | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.